Deping Zhao
Overview
Explore the profile of Deping Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yi C, Bian D, Wang J, Hu S, Sun L, Yan Y, et al.
Nat Commun
. 2025 Feb;
16(1):1932.
PMID: 39994201
The efficacy and safety of induction-immunotherapy followed by surgery for unresectable Stage III non-small cell lung cancer (NSCLC) remain challenging. In this open-label, single-center, phase II clinical umbrella trial (ChiCTR2000035367),...
2.
Lei X, Zhao D, Chen T, Li Q, Xue A, Hu Z, et al.
Phytomedicine
. 2025 Feb;
138:156365.
PMID: 39904199
Background: The Zhimu-Huangbai herb-pair (ZB) is commonly used to treat depression. Previous research has verified that ZB is effective as an antidepressant. Nevertheless, its active components and potential mechanism still...
3.
Cai J, Ruan W, Wang Z, Liu G, Yang B, Wang H, et al.
Genes Dis
. 2025 Jan;
12(2):101338.
PMID: 39830029
No abstract available.
4.
Dong Y, Xu L, Wen J, Si H, Yu J, Chen T, et al.
JTO Clin Res Rep
. 2025 Jan;
6(1):100763.
PMID: 39758598
Objective: The potential survival benefits of adjuvant immunotherapy for resectable NSCLC after neoadjuvant chemoimmunotherapy, and the optimal number of adjuvant immunotherapy cycles, remain uncertain. This study aims to evaluate the...
5.
Zhao M, Xue G, He B, Deng J, Wang T, Zhong Y, et al.
Nat Commun
. 2025 Jan;
16(1):84.
PMID: 39747216
Diagnosing lung cancer from indeterminate pulmonary nodules (IPLs) remains challenging. In this multi-institutional study involving 2032 participants with IPLs, we integrate the clinical, radiomic with circulating cell-free DNA fragmentomic features...
6.
E H, Zhang L, Yang Z, Xu L, Wang T, Guo J, et al.
J Exp Clin Cancer Res
. 2024 Dec;
43(1):324.
PMID: 39702326
Background: Thymic epithelial tumors (TETs) are infrequent malignancies that arise from the anterior mediastinum. Therapeutic options for TETs, especially thymic carcinoma (TC), remain relatively constrained. This study aims to investigate...
7.
Li C, Gao P, Zhuang F, Wang T, Wang Z, Wu G, et al.
Research (Wash D C)
. 2024 Nov;
7:0531.
PMID: 39525611
[This corrects the article DOI: 10.34133/2022/9873203.].
8.
Yang D, Deng J, Huang S, He H, Dai C, Zhao D, et al.
Thromb Res
. 2024 Nov;
244:109193.
PMID: 39489046
Introduction: The clinical presentation, outcomes, and anticoagulation strategies in patients with lung cancer-associated isolated distal deep vein thrombosis (LC-iDDVT) are not well-defined. Materials And Methods: The study included 593 patients...
9.
Shen X, Zhao M, Deng J, Chen T, Wen J, Xu L, et al.
Eur J Cardiothorac Surg
. 2024 Sep;
66(3).
PMID: 39298445
Objectives: Despite excellent 5-year survival, there are limited data on the long-term prognostic characteristics of clinical stage IA part-solid lung adenocarcinoma. The objective was to elucidate the dynamics of prognostic...
10.
Li C, Gao P, Zhuang F, Wang T, Wang Z, Wu G, et al.
Research (Wash D C)
. 2024 Sep;
7:0473.
PMID: 39268501
Lung ischemia-reperfusion injury (IRI) stands as the primary culprit behind primary graft dysfunction (PGD) after lung transplantation, yet viable therapeutic options are lacking. In the present study, we used a...